STARS Webinar - Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials-Deutsche Audioübersetzung

Video Transcription

Video Summary

This webinar discussed the importance of finding the right dose using patient data in the early phases of clinical trials. The speakers emphasized the need for patient-centered dosing and optimizing treatment outcomes while minimizing toxicity. They highlighted the role of patient report outcomes (PROs) in capturing subjective experiences and ensuring that patients' perspectives are considered in treatment decisions. The speakers also shared their personal experiences as patient advocates and discussed their involvement in initiatives such as the Patient-Centered Dosing Initiative (PCDI).<br /><br />The webinar highlighted the misconceptions surrounding patient-reported outcomes and data, emphasizing the importance of integrating patient perspectives in clinical trials. It also discussed the need for improved dosing strategies in phase 1 clinical trials and the potential for flexible dosing options based on individual patient characteristics.<br /><br />The speakers stressed the importance of collaboration between patients, healthcare professionals, and researchers to optimize dosing strategies and improve treatment outcomes. They provided insights into their own experiences and encouraged other patient advocates to get involved in research and advocacy efforts.<br /><br />Overall, the webinar shed light on the significance of patient-centered dosing and the need to consider individual patient characteristics and experiences in clinical trials and treatment decisions. It highlighted the importance of ongoing collaboration and communication between patients and healthcare professionals to ensure the best possible outcomes for patients.

Asset Subtitle

(German Audio Translation)

Keywords

patient data

clinical trials

patient-centered dosing

treatment outcomes

patient report outcomes

Patient-Centered Dosing Initiative

misconceptions

phase 1 clinical trials

collaboration

individual patient characteristics